Helen Of Troy Sales Decline As Beauty Products Demand Softens; Shares Plunge

Zinger Key Points
  • Third-quarter sales decline 3.4% year-on-year.
  • Helen Of Troy lowers FY25 revenue outlook to $1.888 billion - $1.913 billion.

Helen Of Troy Ltd HELE shares traded lower premarket on Wednesday after the company reported third-quarter earnings.

The company posted a third-quarter sales decline of 3.4% year-on-year to $530.706 million, missing the analyst consensus estimate of $534.31 million.

The decrease in sales was primarily driven by a decline in sales of Beauty & Wellness.

Total net sales revenue for the Home & Outdoor segment increased 4.3% and Beauty & Wellness plunged 9.3%. Adjusted EPS of $2.67 beat the analyst consensus estimate of $2.60.

Gross profit margin increased 90 basis points to 48.9%. The operating margin contracted 530 basis points to 14.2%, and operating income for the quarter decreased 29.7% to $75.1 million.

Non-GAAP adjusted EBITDA decreased 1% to $96.8 million, with a margin of 18.2% compared to 17.8%.

As of quarter-end, the company held $40.8 million in cash and equivalents. Operating cash flow for nine months totaled $78.2 million, with a free cash flow of $56.1 million, both down year over year.

“Beauty & Wellness was negatively impacted by a weak illness season globally, including the weakest in the U.S. in the past eight years (excluding the COVID anomaly year of 2020-2021) and continued softness in Beauty,” said CEO Noel M. Geoffroy.

Inventory was $450.7 million versus $426 million in the third quarter of 2024. Helen Of Troy reaffirmed a one-time pre-tax restructuring charge of approximately $50 million – $55 million over the duration of Project Pegasus, expected to be completed during fiscal 2025.

Outlook: Helen Of Troy lowered the FY25 revenue outlook from $1.885 billion – $1.935 billion to $1.888 billion – $1.913 billion against an estimate of $1.924 billion.

HELE revised its FY25 adjusted EPS outlook from $7.00 – $7.50 to $7.15 – $7.40 versus an estimate of $7.21.

It revised FY25 adjusted EBITDA guidance from $287 million-$297 million to $292 million – $295 million.

Price Action: HELE shares are trading lower by 4.06% at $56.88 in premarket at the last check on Wednesday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!